Jamjoom Pharmaceuticals Factory Company

SR 113.80As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:4015Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 3Y CAGR 10.06%
Div yield 3.87%
ROE 27.82%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.38
PE TTM 16.45
TSR TTM (24.73%)
Mkt cap SR 7.966B
ROIC 28.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 121
6.06%
(5.11%)
Hold 9|3|4|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
2.40
2.30
2.21
2.35
24.25%
14.23%
7.59%
5.53%
RevenueSR M
844.7
824.8
807.6
848.7
5.15%
0.88%
(6.34%)
(0.68%)
Peers (US$2.198B)
Cap (US$)
PE
3.324B
15.14x
874.1M
17.42x
Capital
TTM
5Y
10Y
Leveragex
0.292
0.033
0.024
EBIT/Intx
1.176
0.209
0.229
Own earn%
37.26
115.30
102.35
Sh yield%
26.16
27.29
27.31
Owners
Insiders/Inst%
3.09
55.53
Short interest%
3.93
SBC / revenue%
5.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
17–28
$1 testx
—
Incr. ROIC%
28